Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raviraj Kulathila

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylaseBrian Raymer, Michael Kavana, Allen Price, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1aRaviraj Kulathila, Kirk Clark, Paula Savage, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 21, 2009
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9Raviraj Kulathila, Brian Vash, David Sage, et al.
Journal of Applied Crystallography|August 25, 2021
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screeningShuo Sui, Anne Mulichak, Raviraj Kulathila, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2011
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13Ruben A Tommasi, Sven Weiler, Leslie W McQuire, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactionsB Barry Touré, Karen Miller-Moslin, Naeem Yusuff, et al.
Structure (London, England : 1993)|January 31, 2017
Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform SelectivityXiaoling Xie, Daniel Baird, Kimberly Bowen, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 InhibitorYoung Shin Cho, Julian R Levell, Gang Liu, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1Julian R Levell, Thomas Caferro, Gregg Chenail, et al.
Journal of Medicinal Chemistry|May 9, 2009
Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13Lauren G Monovich, Ruben A Tommasi, Roger A Fujimoto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylaseBrian Raymer, Michael Kavana, Allen Price, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1aRaviraj Kulathila, Kirk Clark, Paula Savage, et al.
Acta Crystallographica. Section D, Biological Crystallography|January 21, 2009
The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9Raviraj Kulathila, Brian Vash, David Sage, et al.
Journal of Applied Crystallography|August 25, 2021
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screeningShuo Sui, Anne Mulichak, Raviraj Kulathila, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2011
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13Ruben A Tommasi, Sven Weiler, Leslie W McQuire, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactionsB Barry Touré, Karen Miller-Moslin, Naeem Yusuff, et al.
Structure (London, England : 1993)|January 31, 2017
Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform SelectivityXiaoling Xie, Daniel Baird, Kimberly Bowen, et al.
ACS Medicinal Chemistry Letters|October 24, 2017
Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 InhibitorYoung Shin Cho, Julian R Levell, Gang Liu, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1Julian R Levell, Thomas Caferro, Gregg Chenail, et al.
Journal of Medicinal Chemistry|May 9, 2009
Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13Lauren G Monovich, Ruben A Tommasi, Roger A Fujimoto, et al.
Pageof 2